Paper2136802
Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia.
Pui CH and 9 others. Blood, 1990. Cited by 142 papers, by iCite.
Cite this record
ConductScience Library. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Papers, record 2136802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2136802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia-Lymphoma, Adult T-Cell | Major topic |
| Age Factors | |
| Antigens, CD | |
| Antigens, Differentiation, T-Lymphocyte | |
| CD3 Complex | |
| Child | |
| Chromosome Aberrations | |
| Chromosome Disorders | |
| Humans | |
| Multivariate Analysis | |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
| Prognosis | |
| Receptors, Antigen, T-Cell |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-20180 | NCI NIH HHS | United States | P01CA020180 | PubMed and NIH | NIH RePORTER |
| CA-21765 | NCI NIH HHS | United States | P30CA021765 | PubMed and NIH | NIH RePORTER |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40541190 | iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40541190 | PubMed |
| 39715467 | CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure? | Blood Adv | 2025 | https://conductscience.org/library/papers/39715467 | PubMed |
| 38832423 | Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia. | Haematologica | 2024 | https://conductscience.org/library/papers/38832423 | PubMed |
| 38383515 | Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. | Nat Commun | 2024 | https://conductscience.org/library/papers/38383515 | PubMed |
| 37214576 | Mediastinal lesions in children. | World J Clin Cases | 2023 | https://conductscience.org/library/papers/37214576 | PubMed |
| 36612092 | Adoptive Cell Therapy for T-Cell Malignancies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612092 | PubMed |
| 36523990 | Chimeric antigen receptor T-cell therapy for T-ALL and AML. | Front Oncol | 2022 | https://conductscience.org/library/papers/36523990 | PubMed |
| 34620233 | CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit? | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/34620233 | PubMed |
| 33867734 | Analysis of the Expression of the TRBC1 in T lymphocyte tumors. | Indian J Hematol Blood Transfus | 2021 | https://conductscience.org/library/papers/33867734 | PubMed |
| 33081391 | Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33081391 | PubMed |
| 31884955 | Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/31884955 | PubMed |
| 31570389 | The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia. | Cold Spring Harb Perspect Med | 2020 | https://conductscience.org/library/papers/31570389 | PubMed |
| 31205572 | BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. | J Cancer | 2019 | https://conductscience.org/library/papers/31205572 | PubMed |
| 30938820 | Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children. | J Natl Cancer Inst | 2019 | https://conductscience.org/library/papers/30938820 | PubMed |
| 30891427 | Chimeric Antigen Receptors for T-Cell Malignancies. | Front Oncol | 2019 | https://conductscience.org/library/papers/30891427 | PubMed |
| 29131157 | Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies. | Nat Med | 2017 | https://conductscience.org/library/papers/29131157 | PubMed |
| 28174276 | Synergistic antileukemic therapies in NOTCH1-induced T-ALL. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28174276 | PubMed |
| 26174476 | Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China. | BMC Pediatr | 2015 | https://conductscience.org/library/papers/26174476 | PubMed |
| 24474641 | Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea. | Int J Hematol | 2014 | https://conductscience.org/library/papers/24474641 | PubMed |
| 21474675 | Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). | Blood | 2011 | https://conductscience.org/library/papers/21474675 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD1C | 911 | PubTator's text mining | https://conductscience.org/library/genes/911 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD5 | 921 | PubTator's text mining | https://conductscience.org/library/genes/921 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| MME | 4311 | PubTator's text mining | https://conductscience.org/library/genes/4311 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2136802
GET https://conductscience.org/api/papers/v1/2136802/cited_by?page=2